The Valley Desk

NCT01465958 · Interventional trial

Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency

Overall registry status Completed

Phase 4

Conditions Primary Immunodeficiency

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov